πŸ‡ΊπŸ‡Έ FDA
Patent

US 12371420

Polymorphs of Selinexor

granted A61KA61K31/497A61P

Quick answer

US patent 12371420 (Polymorphs of Selinexor) held by Karyopharm Therapeutics Inc. expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Karyopharm Therapeutics Inc.
Grant date
Tue Jul 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/497, A61P, A61P35/00